Preoperative cardiopulmonary assessment for video-assisted thoracoscopic surgery (VATS) pulmonary resection: a narrative review

Authors:

Abstract
Background and Objective: Lung cancer remained the leading cause of cancer-related death in the United States in 2024, and surgery remains the mainstay of curative therapy. Despite the improved safety profile of video-assisted thoracoscopic surgery (VATS), pulmonary resection still poses unique physiologic demands on patients, who often are older and have cardiovascular and pulmonary risk factors. This review assimilates current recommendations for the cardiopulmonary assessment of patients before lung cancer resection from international guidelines into one succinct document for thoracic surgeons. Methods: A narrative review of the literature was performed using a search of PubMed, ClinicalKey, and UpToDate using a variable combination of the terms “video-assisted thoracoscopic surgery”, “preoperative assessment”, “preoperative cardiac risk stratification”, “preoperative pulmonary risk stratification”, and “pulmonary function testing”. Articles were hand-selected and citation chaining was performed to identify relevant studies. Whenever possible, the authors cited original articles, systematic reviews, meta-analyses, or randomized controlled trials. Articles cited were written in English between 1961 and 2024, with select articles added in 2025. Key Content and Findings: This narrative review details the American Heart Association (AHA)/American College of Cardiology (ACC)’s comprehensive cardiac risk assessment guidelines and compares them to similar guidelines published by the European Society of Cardiology (ESC), the Canadian Cardiovascular Society (CCS), and the Japanese Circulation Society (JCS). It also reviews the American College of Chest Physicians’ (ACCP’) guidelines for the preoperative pulmonary assessment of patients prior to pulmonary resection and compares these to similar guidelines published by the European Respiratory Society (ERS), the British Thoracic Society (BTS), and the Japanese Association of Chest Surgery (JACS). Conclusions: This narrative review functions as an overview of multiple international guidelines for the appropriate cardiac and pulmonary risk stratification of patients prior to pulmonary resection for lung cancer. It summarizes up-to-date recommendations for thoracic surgeons, including a comparison of cardiac risk assessment models, serum biomarkers, recommendations for pulmonary function and exercise testing, and the benefits of preoperative pulmonary prehabilitation.